N-Desmethyl Galanthamine is primarily studied for its potential therapeutic applications, particularly in the field of neurology. It is known to act as an acetylcholinesterase inhibitor, which makes it a candidate for treating neurodegenerative disorders such as Alzheimer's disease. By inhibiting the breakdown of acetylcholine, it helps enhance cholinergic neurotransmission, which is crucial for memory and cognitive functions. Additionally, its pharmacological properties are being explored for their potential in managing other cognitive impairments and neurological conditions. Research is ongoing to fully understand its efficacy and safety profile in clinical settings.